Índice preditor de reserva ovariana (ORPI) para controle de estimulação ovariana individualizado


Autoria(s): Oliveira, Joao Batista A.; Petersen, Claudia G.; Mauri, Ana L.; Cavagna, Mario; Baruffi, Ricardo L R.; Franco Junior, Jose Gonçalves
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

03/05/2013

Resumo

Objective: to expand the evaluation of a new ovarian response prediction index (ORPI), which was based on the AMH, AFC and age, and to verify its reability as a predictor of ovarian response to stimulation in assisted reproductive technology (ART) cycles. Methods: A total of 129 patients enrolled in the ICSI programme were included. The ORPI values were calculated by multiplying the AMH level (ng/ml) by the number of antral follicles (2-9 mm), and the result was divided by the age (years) of the patient (ORPI=(AMH × AFC)/Patient age). Results: Spearman's test revealed significant correlations (P<0.0001) between the ORPI and the number of oocytes collected and the number of follicles. Logistic regression revealed that ORPI values were significantly associated with the likelihood of collecting ≥4 oocytes (OR=45.56), ≥4 MII oocytes (OR=6.01) and ≥15 oocytes (OR=6.15; P<0.0001). Based on the ROC curves, the ORPI accurately predicted a low ovarian response (<4 oocytes retrieved; area under the curve (AUC):0.91), collection of ≥4 MII oocytes (AUC:0.85) and an excessive ovarian response (≥15 oocytes retrieved; AUC:0.89). Conclusions: The ORPI exhibited an excellent ability to predict a low ovarian response and a good ability to predict a collection of ≥ 4 MII oocytes, an excessive ovarian response. The ORPI might be used to improve the cost-benefit ratio of ovarian stimulation regimens by guiding the selection of medications and by modulating the doses and regimens according to the actual needs of the patients. © Todos os direitos reservados a SBRA - Sociedade Brasileira de Reprodução Assistida.

Formato

77-83

Identificador

Jornal Brasileiro de Reproducao Assistida, v. 17, n. 2, p. 77-83, 2013.

1517-5693

1518-0557

http://hdl.handle.net/11449/75350

2-s2.0-84876865438

Idioma(s)

eng

por

Relação

Jornal Brasileiro de Reproducao Assistida

Direitos

closedAccess

Palavras-Chave #Age #Anti-Mullerian hormone #Antral follicles #Individualized controlled ovarian stimulation #Ovarian response prediction index #cetrorelix #chorionic gonadotropin #leuprorelin #luteinizing hormone #Muellerian inhibiting factor #recombinant follitropin #adult #age #cost benefit analysis #drug dose increase #female #human #major clinical study #named inventories, questionnaires and rating scales #oocyte #ovarian response prediction index #ovary follicle #ovary function #transvaginal echography
Tipo

info:eu-repo/semantics/article